Following the literature reporting the association between case reports and aspiration under anesthesia and the study with gastric ultrasound highlighting the risk of increased gastric content in patients taking GLP-1 RAs [10, 11], in June 2023, the American Society of Anesthesiologists issued guidelines recommending preoperative withholding of GLP-1 RAs used for type 2 diabetes management and weight loss before surgical procedures without any change in the current ASA fasting rules [33]. Here, GCG is linked to type 2 diabetes mellitus.